Bristol Myers: cancer treatment results -April 09, 2024 at 09:52 am EDT

Bristol Myers announces that KRAZATI in combination with cetuximab demonstrates clinically meaningful activity as a targeted treatment option for patients with previously treated locally advanced or...

Related Keywords

Texas ,United States ,American ,Anne Kerber ,Scott Kopetz ,Bristol Myers ,American Association For Cancer Research ,Department Of Gastrointestinal Medical Oncology ,Head Of Late Stage Clinical Development ,Bristol Myers Squibb ,University Of Texas Md Anderson Cancer Center ,American Association ,Cancer Research ,Gastrointestinal Medical Oncology ,Senior Vice President ,Late Stage Clinical Development ,Cellular Therapy ,Markets ,